Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. November 2025 08:00 ET | Quelle: Curonix LLC

Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stage of Growth

Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stag
02. Oktober 2025 08:00 ET | Quelle: Curonix LLC

Curonix Publishes Results for the First and Only IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA 510(k) Expanded Indication for Treating Chronic Craniofacial Pain

Curonix Publishes Results for IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA Expanded Indication for Treating Chronic Craniofacial Pain
18. September 2025 08:00 ET | Quelle: Curonix LLC

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution
27. März 2025 08:00 ET | Quelle: Curonix LLC

Curonix Unveils NervPulse™ Therapy: Setting a New Standard in Nerve-Specific Peripheral Nerve Stimulation (PNS) Therapy

Curonix LLC proudly introduces NervPulseTherapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation.
30. Januar 2025 07:00 ET | Quelle: Curonix LLC

Curonix leads the PNS market with expanded MR Labeling for 3T Full-Body MRI Scans for its Freedom® Peripheral Nerve Stimulator (PNS) System

POMPANO BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, is proud to announce the...
04. Dezember 2024 08:00 ET | Quelle: Curonix LLC

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines for the Management of Chronic Pain

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines
09. Juli 2024 08:00 ET | Quelle: Curonix LLC

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.
18. Januar 2024 08:00 ET | Quelle: Curonix LLC

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
01. November 2023 09:00 ET | Quelle: Curonix LLC

Curonix Celebrates 1st Anniversary

POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...
10. August 2023 08:00 ET | Quelle: Curonix LLC

Retrospective clinical study highlights the effectiveness of Curonix’s Freedom® PNS System in reducing pain scores and improving patient satisfaction

POMPANO BEACH, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to freeing patients from chronic pain, announced the publication of a retrospective study...

Nächste Seite